-
- 抗原 See all LTA 抗体
- LTA (Lymphotoxin-alpha (LTA))
-
抗原表位
- AA 1-205
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This LTA antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 原理
- Rabbit polyclonal antibody raised against a full-length human LTA protein.
- 序列
- MTPPERLFLP RVRGTTLHLL LLGLLLVLLP GAQGLPGVGL TPSAAQTARQ HPKMHLAHST LKPAAHLIGD PSKQNSLLWR ANTDRAFLQD GFSLSNNSLL VPTSGIYFVY SQVVFSGKAY SPKATSSPLY LAHEVQLFSS QYPFHVPLLS SQKMVYPGLQ EPWLHSMYHG AAFQLTQGDQ LSTHTDGIPH LVLSPSTVFF GAFAL
- 交叉反应
- 人
- 产品特性
- Antibody reactive against mammalian transfected lysate.
- 免疫原
- LTA (AAH34729.1, 1 a.a. ~ 205 a.a) full-length human protein.
- Top Product
- Discover our top product LTA Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- In 1x PBS, pH 7.4
- 注意事项
- Aliquot to avoid repeated freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Targeted inhibition of phosphatidyl inositol-3-kinase p110?, but not p110?, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers." in: Apoptosis : an international journal on programmed cell death, Vol. 18, Issue 4, pp. 509-20, (2013) (PubMed).
: "
-
Targeted inhibition of phosphatidyl inositol-3-kinase p110?, but not p110?, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers." in: Apoptosis : an international journal on programmed cell death, Vol. 18, Issue 4, pp. 509-20, (2013) (PubMed).
-
- 抗原
- LTA (Lymphotoxin-alpha (LTA))
- 别名
- LTA (LTA 产品)
- 别名
- LT antibody, TNFB antibody, TNFSF1 antibody, LT-[a] antibody, LT-alpha antibody, LT[a] antibody, LTalpha antibody, Ltx antibody, TNF-beta antibody, Tnfb antibody, Tnfsf1b antibody, hlb382 antibody, lymphotoxin alpha antibody, lymphotoxin A antibody, LTA antibody, Lta antibody
- 物质类
- Chemical
- 背景
-
Full Gene Name: lymphotoxin alpha (TNF superfamily, member 1)
Synonyms: LT,TNFB,TNFSF1 - 基因ID
- 4049
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-